DTaP

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

70 competitors in Diphtheria

#DrugCompanyPhaseTrials

1

Comparator: Pbo

Merck & Co.

Approved

22

Boostrix

GSK

Approved

23

BCG Vaccine

GGynecologic Oncology Group

Approved

14

GSK 257049

GSK

Phase 3

25

Havrix

GSK

Phase 3

16

Infanrix

GSK

Phase 3

17

DTaP

Pfizer

Approved

48

Rsvpref3 Vaccine

GSK

Phase 2

19

Acthib

GSK

Phase 3

110

REVAXIS

Sanofi

Phase 3

1Show 10 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Immunogenicity6 trials

Evaluation of the Safety and Immunogenicity of Simultaneously Administration of sIPV and DTaP

Completed·CChina National Biotec Group Company Limited·Phase 4·NCT04054882·702 enrolled

Efficacy, Safety, and Immunogenicity of V260 in Healthy Chinese Infants (V260-024)

Completed·Merck & Co.·Phase 3·NCT02062385·4,040 enrolled

Evaluation of Safety and Immunogenicity of Combined Immunization of sIPV, DTaP and HepA

Unknown status·CChina National Biotec Group Company Limited·Phase 4·NCT04636827·600 enrolled

Show 3 more trials

Clinic Trial to Evaluate the Safety and Immunogenicity of Combined Immunization of sIPV and DTaP

Unknown status·CChina National Biotec Group Company Limited·Phase 4·NCT04053010·702 enrolled

Evaluation of Immunogenicity and Safety of Combined Immunization of sIPV, DTaP and MMR

Unknown status·CChina National Biotec Group Company Limited·Phase 4·NCT04638985·600 enrolled

Safety and Immunogenicity of Tdap Vaccine Compared to DTaP Vaccine in Children 4 to 6 Years of Age

Completed·Sanofi·Phase 3·NCT00467519·1,045 enrolled

Diphtheria4 trials

Trial Evaluating a 13-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants

Completed·Pfizer·Phase 3·NCT01200368·551 enrolled

Adsorption of Cell-free Diphtheria and Tetanus (Three-component) Combined With Vaccine Phase III Clinical Trial

Recruiting·CChangchun BCHT Biotechnology Co.·Phase 3·NCT07112144·1,650 enrolled

A Trial Evaluating a 7-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants.

Completed·Pfizer·Phase 4·NCT01250756·321 enrolled

Show 1 more trial

Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine

Recruiting·IInstitute of Medical Biology, Chinese Academy of Medical Sciences·Phase 1·NCT06184542·460 enrolled

Vaccines1 trial

Apnea in Hospitalized Preterm Infants Following the Administration of Routine Childhood Vaccines

Completed·—·Phase 4·NCT03530124·223 enrolled

Immune Response1 trial

A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants

Completed·Novartis·Phase 3·NCT00474526·4,545 enrolled

Vaccination1 trial

Fever After Simultaneous Versus Sequential Vaccination in Young Children

Completed·—·Phase 4·NCT03165981·221 enrolled

Details

Drug Info

Related News